Related references
Note: Only part of the references are listed.Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15-23 months in Burkina Faso
Sodiomon B. Sirima et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
Sodiomon B. Sirima et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial
Firdausi Qadri et al.
LANCET (2021)
Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children
Priyanka D. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study
Mohammad Tahir Yousafzai et al.
Lancet Global Health (2021)
Changes in historical typhoid transmission across 16 US cities, 1889-1931: Quantifying the impact of investments in water and sewer infrastructures
Maile T. Phillips et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Tenacious Endemic Typhoid Fever in Samoa
Michael J. Sikorski et al.
CLINICAL INFECTIOUS DISEASES (2020)
Intestinal Perforations Associated With a High Mortality and Frequent Complications During an Epidemic of Multidrug-resistant Typhoid Fever in Blantyre, Malawi
Franziska Olgemoeller et al.
CLINICAL INFECTIOUS DISEASES (2020)
Complications and mortality of typhoid fever: A global systematic review and meta-analysis
Christian S. Marchello et al.
JOURNAL OF INFECTION (2020)
Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans
Sushant Sahastrabuddhe et al.
CLINICAL INFECTIOUS DISEASES (2019)
Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi
James E. Meiring et al.
CLINICAL INFECTIOUS DISEASES (2019)
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial
Katherine Theiss-Nyland et al.
CLINICAL INFECTIOUS DISEASES (2019)
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial
Katherine Theiss-Nyland et al.
CLINICAL INFECTIOUS DISEASES (2019)
A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper
Matthew B. Laurens et al.
CLINICAL INFECTIOUS DISEASES (2019)
Typhoid Vi-conjugate vaccine for outbreak control in Zimbabwe
Ioana D. Olaru et al.
LANCET INFECTIOUS DISEASES (2019)
Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal
Mila Shakya et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): An Overview and Lessons Learned
Caitlin Barkume et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid
Carl D. Britto et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial
Celina Jin et al.
LANCET (2017)
The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK
James E. Meiring et al.
VACCINE (2017)
The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys
Thomas C. Darton et al.
BMJ OPEN (2017)
What Have We Learned From the Typhoid Fever Surveillance in Africa Program?
Stephen Baker et al.
CLINICAL INFECTIOUS DISEASES (2016)
Safety and Immunogenicity of a Vi Polysaccharide-Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study
Vadrevu Krishna Mohan et al.
CLINICAL INFECTIOUS DISEASES (2015)
Share Paper
